Oxidative protein damage with carbohydrates and lipids in uremia: 'Carbonyl stress'

被引:51
作者
Inagi, R [1 ]
Miyata, T [1 ]
机构
[1] Tokai Univ, Sch Med, Inst Med Sci, Kanagawa 2591193, Japan
关键词
uremic complication; dialysis-related amyloidosis; atherosclerosis; advanced glycation end products (AGEs); non-enzymatic reaction; oxidative stress;
D O I
10.1159/000014380
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic uremia appears to be in a state of an increased oxidative stress. Under oxidative stress, proteins are modified directly by reactive oxygen species with the eventual formation of oxidised amino acids. Proteins are also modified indirectly with reactive carbonyl compounds formed by the autoxidation of carbohydrates and lipids, with the eventual formation of the advanced glycation/lipoxidation end products (AGEs/ALEs). AGEs, pentosidine and carboxymethyllysine (CML), and ALE, malondialdehyde (MDA)-lysine, are elevated in plasma and matrix proteins of uremic patients several times above normal subjects. Precursor carbonyl compounds derived from carbohydrates and lipids are indeed elevated in uremic circulation. Uremia thus appears to be in a state of carbonyl overload with potentially damaging proteins (carbonyl stress). Carbonyl stress might be relevant to long-term complications associated with chronic renal failure and dialysis, such as dialysis-related amyloidosis and atherosclerosis. Immunohistochemical studies identified carbonyl stress in long-lived amyloid deposits and vascular lesions. Proteins modified under carbonyl stress exhibit several biological activities, which might, at least in part, account for the development of joint and vascular complications in uremia.
引用
收藏
页码:95 / 98
页数:4
相关论文
共 35 条
[31]   Advanced glycation endproducts stimulate mitogen-activated protein kinase and proliferation in rabbit vascular smooth muscle cells [J].
Satoh, H ;
Togo, M ;
Hara, M ;
Miyata, T ;
Han, K ;
Maekawa, H ;
Ohno, N ;
Hashimoto, Y ;
Kurokawa, K ;
Watanabe, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 239 (01) :111-115
[32]  
Stein Guenter, 1998, Journal of the American Society of Nephrology, V9, p240A
[33]  
Sugiyama S, 1998, J AM SOC NEPHROL, V9, P1681
[34]   Advanced oxidation protein products as a novel marker of oxidative stress in uremia [J].
WitkoSarsat, V ;
Friedlander, M ;
CapeillereBlandin, C ;
NguyenKhoa, T ;
Nguyen, NT ;
Zingraff, J ;
Jungers, P ;
DescampsLatscha, B .
KIDNEY INTERNATIONAL, 1996, 49 (05) :1304-1313
[35]  
YEUNG JHK, 1991, METHOD FIND EXP CLIN, V13, P23